Register Now: Advances in Spectroscopy for Pharma and Biopharmaceutical Analysis Symposium
Blog|Articles|January 2, 2024

Histamine Determined Using Fluorescence Detection System

Author(s)Aaron Acevedo

Scientists from King Khalid University in Abha, Saudi Arabia and Al-Azhar University in Cairo, Egypt have created a fluorescence chemo sensor to selectively determine histamine in human plasma samples. Their work was published in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy (1).

Histamine can impact different physiological functions, such as acid secretion, neurotransmission, and immune responses, through H1, H2, H3, and H4 receptors. Histamine imbalances are linked to different pathological illnesses, such as autoimmune and inflammatory diseases. They can affect different processes, such as releasing stomach acid (H2 receptors), releasing neurotransmitters in the nervous system (H3 receptors), and affecting the contraction of smooth muscle (H1) receptors. These receptors are vital to understanding diseases, so monitoring and maintaining physiological balance in histamine production is essential.

In this study, scientists created a novel fluorescence chemo sensor to measure histamine in different forms. This detection method consists of detecting specific molecules or ions, generating a measurable signal in response. It is based on the phenomena of chemo sensors undergoing transformations upon interacting with the target compound.

Histamine quantification, when conducted in a plasma matrix, can be used to examine mass cell activation and differentiate between allergic reactions. The scientists created a fluorescent-based sensor for determine histamine in the human plasma matrix. The method was based on chemical transformation, turning histamine into N-(2-(1H-imidazol-4-yl) ethyl)-2-bromoacetamide, which is a fluorescent product that differs from normal histamine molecules.

The transformation itself involved chemical reactions between trimethylamine, with the final product becoming excited at 250 nm and emitting a signal at 340 nm. Using histamine determination, the scientists obtained significant concentration-dependent fluorescence enhancement. After the measurements, the procedures were examined with ICH M10 recommendations, to check the system’s accuracy, precision, selectivity, and robustness. Overall, the method showed a limit of quantification of 0.25 ng/mL and dynamic detection throughout a linearity range of 1–200 ng/mL, which allowed for accurate histamine assessment in the plasma matrix.

Reference

(1) Alqahtani, A.; Alqahtani, T.; Abdelazim, A. H. Development of Fluorescence Chemo Sensor for Selective Histamine Determination in Spiked Human Plasma Samples. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2024, 308, 123711. DOI: https://doi.org/10.1016/j.saa.2023.123711


Related to this article

Curated 2026 Evergreen Content from Spectroscopy. ©  Chanakarn -chronicles-stock.adobe.com
Spectroscopy's editors gather 143 evergreen articles from 2026, including tutorials, terminology guides, technique reviews, application surveys, peer-reviewed research and the magazine's long-running columns, and organize them by subject so readers can build lasting knowledge one topic at a time.
Spectral Frontiers: Seeing the Unseeable Microspectroscopy
Microspectroscopy, the marriage of spectroscopic chemical identification with microscopic spatial resolution, has advanced from Perkin-Elmer's first commercial infrared microspectrometer in 1953 to today's nanoscale AFM-IR probes, synchrotron-brightness infrared beamlines, and compact hyperspectral tissue imaging devices being developed for AI-assisted cancer detection.